2024 ASCO | Mabwell to Present Clinical Data of 9MW2821 in Multiple Advanced Solid Tumor
SHANGHAI, April 25, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with an entire industry chain, announced that the Phase I/II clinical study results of the...
- April 26, 2024 12:00 AM AEST
- Cision
ISH Tecnologia Applauded by Frost & Sullivan for Its Market-leading Position and Helping Secure and Grow Latin American Organizations
ISH Tecnologia has a strong position in the Brazilian market, serving over 600 customers across multiple high-profile industries, including oil and energy, financial services, and manufacturing...
- April 26, 2024 12:00 AM AEST
- Cision